Praxis Precision Medicines (PRAX) Leases (2022 - 2025)
Praxis Precision Medicines has reported Leases over the past 4 years, most recently at $92000.0 for Q4 2025.
- Quarterly results put Leases at $92000.0 for Q4 2025, down 91.87% from a year ago — trailing twelve months through Dec 2025 was $92000.0 (down 91.87% YoY), and the annual figure for FY2025 was $92000.0, down 91.87%.
- Leases for Q4 2025 was $92000.0 at Praxis Precision Medicines, down from $362000.0 in the prior quarter.
- Over the last five years, Leases for PRAX hit a ceiling of $3.5 million in Q1 2022 and a floor of $92000.0 in Q4 2025.
- Median Leases over the past 4 years was $2.0 million (2023), compared with a mean of $1.9 million.
- Biggest five-year swings in Leases: decreased 22.26% in 2023 and later tumbled 91.87% in 2025.
- Praxis Precision Medicines' Leases stood at $2.9 million in 2022, then fell by 28.85% to $2.1 million in 2023, then crashed by 45.2% to $1.1 million in 2024, then tumbled by 91.87% to $92000.0 in 2025.
- The last three reported values for Leases were $92000.0 (Q4 2025), $362000.0 (Q3 2025), and $626000.0 (Q2 2025) per Business Quant data.